Evidence map›Paper›PMID 29987162›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

CX

Young-In Kim, Joo-Hye Song, Hyun-Jeong Ko, Mi-Na Kweon, Chang-Yuil Kang, Hans-Christian Reinecker, Sun-Young Chang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. The pyruvate-GPR31 axis promotes transepithelial dendrite formation in human intestinal dendritic cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Macrophages in intestinal homeostasis and inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Gut-resident CX3CR1Science immunology · 2020
    Article
  15. Gut-associated IgANature communications · 2019
    Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Young-In KimLaboratory of Microbiology, College of Pharmacy, Ajou University, Suwon 16499, Korea.
Joo-Hye SongGastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Hyun-Jeong KoLaboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon 24341, Korea.
Mi-Na KweonMucosal Immunology Laboratory, Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05535, Korea.
Chang-Yuil KangLaboratory of Immunology, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Gwanak-gu, Seoul 08826, Korea; and.ORCID 0000-0002-1843-6967
Hans-Christian ReineckerGastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; sychang@ajou.ac.kr hans-christian_reinecker@hms.harvard.edu.
Sun-Young ChangLaboratory of Microbiology, College of Pharmacy, Ajou University, Suwon 16499, Korea; sychang@ajou.ac.kr hans-christian_reinecker@hms.harvard.edu.
Ajou University · KRHarvard University · USKangwon National University · KRSeoul National University of Science and Technology · KRUlsan College · KR

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Innate Immune Defense Mechanisms in the IntestineR01AI113333 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI REINECKER, HANS-CHRISTIAN · 2014 to 2025
$5.7M
Antigen Recognition at Intestinal Epithelial InterphasesR01DK068181 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2005 to 2017
$5.2M
Inducible Regulatory B cells IBREGR01AI081807 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2011 to 2015
$1.9M
IL-22 pathway in IBDR01DK091247 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2013 to 2016
$1.4M
NIAID NIH HHS R01 AI081807NIAID NIH HHS R01 AI113333NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK068181NIDDK NIH HHS R01 DK091247
6 · The paper itself

Abstract

Secretory IgA is a key host defense mechanism that controls the intestinal microbiota. We investigated the role of CD11c

Indexed as

AnimalsAntibody FormationB-LymphocytesCD8-Positive T-LymphocytesCX3C Chemokine Receptor 1Immunity, MucosalImmunoglobulin A, SecretoryIntestinal MucosaMacrophagesMiceMice, Inbred C57BLMice, KnockoutCX3C Chemokine Receptor 1Cx3cr1 protein, mouseImmunoglobulin A, Secretory

Identifiers

PMID29987162
PMCPMC6082403
OpenAlexW2856453051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.